Zevia (NYSE:ZVIA) on Tuesday said it has received notice from the New York Stock Exchange informing the company that it is no longer in compliance with listing standards as the average closing price of the company’s Class A common stock was less than $1.00 per share over a consecutive 30Continue Reading
Hailshadow Johnson & Johnson (NYSE:JNJ) announced Tuesday that its FDA-approved cell therapy Carvykti, developed with Legend Biotech (LEGN), outperformed standard of care in a Phase 3 trial for patients with a type of blood cancer called multiple myeloma. Citing interim data from its CARTITUDE-4 trial, the pharma giant said patientsContinue Reading
U.Today – As reported by Bloomberg, banking giant Standard Chartered (OTC:) might be on the verge of launching a dedicated trading desk for and , according to sources close to the matter. This bold step positions Standard Chartered as one of the pioneering global banks to embrace spot cryptocurrency trading.Continue Reading
